Discovery and In-Vivo Characterization of Kv7 Channel Openers through a Phenotypic Approach
- 12 August 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (16) , 17412-17426
Abstract
Despite the availability of approximately 30 antiseizure drugs (ASDs), epilepsy remains a major unmet clinical need, with approximately 30% of epileptic patients experiencing uncontrolled seizures despite an adequately chosen treatment. Polypharmacology is a common feature of many ASDs and polypharmacy is a usual practice to treat epileptic patients. Several approved ASDs were originally discovered through phenotypic screening in rodent models of seizures. To overcome the technical and ethical challenges associated with animal testing, we developed an in vitro assay that recapitulates seizure-related neuronal hyperexcitability phenotypes in a dish. Using this unbiased assay, a new class of urea compounds was discovered. Through optimization, compound 31 (IDOR-1104–0086) was identified as an orally bioavailable and brain-penetrant compound with in vivo efficacy in two rodent models of epilepsy and a favorable tolerability profile. Target deconvolution revealed that these ureas exert their antiseizure effects through activation of KV7 potassium channels, a mechanism consistent with the modulation of neuronal excitability.Keywords
This publication has 29 references indexed in Scilit:
- Targeting Kv7 Potassium Channels for EpilepsyCNS Drugs, 2025
- Channelopathies in epilepsy: an overview of clinical presentations, pathogenic mechanisms, and therapeutic insightsJournal of Neurology, 2024
- The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and BeyondCNS Drugs, 2021
- An Investigation into Retigabine (Ezogabine) Associated Dyspigmentation in Rat Eyes by MALDI Imaging Mass SpectrometryChemical Research in Toxicology, 2019
- The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal ChemistryChemMedChem, 2018
- Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDsEpilepsy & Behavior, 2017
- Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugsSeizure: European Journal of Epilepsy, 2011
- The influence of an endogenous β3 subunit on recombinant GABAA receptor assembly and pharmacology in WSS-1 cells and transiently transfected HEK293 cellsNeuropharmacology, 2000
- Two New Potent Neurotransmitter Release Enhancers, 10,10-Bis(4-Pyridinylmethyl)-9(10H)-Anthracenone and 10,10-Bis(2-Fluoro-4-Pyridinylmethyl)-9(10H)-Anthracenone: Comparison to LinopirdineThe Journal of Pharmacology and Experimental Therapeutics, 1998
- Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerationsEpilepsy Research, 1988